53-year-old man becomes 5th person to be cured of HIV
Researchers have announced that a 53-year-old man in Germany has become the fifth person in history to be cured of HIV. The patient, known as "the Dusseldorf patient," received a stem cell transplant ten years ago and has not taken HIV medication in four years, according to ABC News.
While being the fifth person cured, the Dusseldorf patient is only the third person to be cured through a stem cell transplant. From the time of the procedure, the virus has not been detectable in his body. "It's really cure, and not just, you know, long-term remission," said Dr. Bjorn-Erik Ole Jensen who published the findings of the case. The first reported cure was in 2009.
Stem cell transplants are high-risk procedures that are normally reserved for cancer patients. The Dusseldorf patient was the same, diagnosed with acute myeloid leukemia, a deadly form of blood cancer, just after beginning treatment for HIV, Sky News reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Over 35 million people currently live with HIV, but many cases are managed through medication, allowing them to live fairly normal lives. "Following our intensive research, we can now confirm that it is fundamentally possible to prevent the replication of HIV on a sustainable basis by combining two key methods," Jensen said referring to the anti-retroviral medications along with the transplants. "Further research is now needed into how this can be made possible outside the narrow set of framework conditions."
"Today, I am all the more proud of my worldwide team of doctors who succeeded in curing me of HIV - and at the same time, of course, of leukemia," the patient remarked.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
'A direct, protracted war with Israel is not something Iran is equipped to fight'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Today's political cartoons - April 17, 2024
Cartoons Wednesday's cartoons - political anxiety, jury sorting hat, and more
By The Week US Published
-
Arid Gulf states hit with year's worth of rain
Speed Read The historic flooding in Dubai is tied to climate change
By Peter Weber, The Week US Published
-
Lead poisoning remains a threat
The Explainer The toxin is built into our lives
By Devika Rao, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
OTC birth control arrives amid the battle over reproductive rights
Talking Points Opill will cost $19.99 a month. Democrats are pushing to make it cheaper.
By Joel Mathis, The Week US Published